Immune Network to Start Clinical Trial of Oral Mycobacterium Vaccae in Tuberculosis Patients
August 10, 2011 05:00 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Aug. 10, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF), reports that its business partner Immunitor company has launched a Phase 2 clinical trial of a...
Immunitor Presents V5 Trial Data and Receives Award at TB Conference in Hong Kong
July 09, 2011 06:57 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, July 9, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor's investigators presented final results from its imm01 clinical trial and...
Herbal TB Immunotherapy to be Presented at Hong Kong Conference
July 07, 2011 10:33 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, July 7, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that clinical results from its new tableted form of Immunoxel (Dzherelo) product...
TB Immunotherapy Collaboration Agreement With Stirling Products and Zodiac Capital
May 30, 2011 10:14 ET
|
Immune Network Ltd
Agreement to fast-track introduction of new Immunoxel/Dzherelo tablet as adjunct immunotherapy, especially for MDR-TB
VANCOUVER, British Columbia, May 30, 2011 (GLOBE NEWSWIRE) -- Immune...
Ekomed Agrees to Collaboration on TB Immunotherapy
March 03, 2011 10:07 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, March 3, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Ukrainian company Ekomed LLC has agreed to collaborate with Immune Network and...
Immunitor Presents Positive TB Treatment Data at African Conference
February 28, 2011 06:22 ET
|
Immune Network Ltd
VANCOUVER, B.C., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in...
Immunitor CEO Joins Immune Network Board of Directors
February 14, 2011 05:57 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Feb. 14, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) is pleased to announce that a co-founder of Immunitor, Dr. Aldar Bourinbaiar, has joined Immune's...
Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical Site
January 24, 2011 04:43 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF) a company in the business of development and commercialization of immune therapies, announced...
Immunitor Deal Terms Approved by New Board of Directors
January 17, 2011 05:22 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Jan. 17, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises progress is being made toward the acquisition of Immunitor Inc., a Canadian corporation...
Immunitor Publishes Interim Data From Phase IIb imm01 TB Trial
December 30, 2010 04:41 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Dec. 30, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has published data from the first half of the 120-patient imm01 clinical...